N/A
N=18
The Impact of High-Flow Nasal Cannula on Swallow Function
Swallowing Disorder · Respiratory Insufficiency
Bottom Line
View on ClinicalTrials.gov: NCT03590457 ↗Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcome: Primary: Swallow Frequency Recorded by Surface Electromyography (sEMG) — 1.12; 1.13; 3.91; 1.01 number of swallows
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Airvo 2; High-Flow nasal cannula system (Device)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- Rush University Medical Center
- Primary completion
- Dec 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Swallow Frequency Recorded by Surface Electromyography (sEMG) |
1.12; 1.13; 3.91; 1.01 | — |
Summary
Background: High-flow nasal cannula (HFNC) is a non-invasive heated and humidified oxygen delivery device that is capable of delivering high-flow rates. It is a relatively new modality that has been introduced as an alternative to conventional oxygen therapy. The clinical value of the use of HFNC is not limited to its ventilation and oxygenation effects, it enables the patient to talk and is purported to permit oral feeding during oxygen therapy despite the limited evidence regarding its impact on swallow function. This study will determine the impact of different flow rates of a high-flow nasal cannula on spontaneous swallowing frequency at rest and swallowing effort and timing while swallowing. Methods: This is a prospective study designed to measure swallowing frequency and swallowing effort in fifty healthy adult volunteers. Participants will receive three levels of HFNC flow rates (30, 45, and 60 L/min) through nasal prongs. The study participants will be asked to swallow measured amounts of water and applesauce and subjected to each flow rate for 15 minutes. Swallowing effort measurement through surface electromyography (sEMG) will be recorded at baseline and the three levels of HFNC flow rates interventions.
Eligibility Criteria
Inclusion Criteria
- 21 years of age or older
- No cognitive impairments
Exclusion Criteria
- Less than 21 years old
- History of swallow dysphagia
- History of disease/condition that may cause dysphagia
- Use of medications that may alter swallow function
- Nasal obstruction
- Presence of tracheostomy tube
Data sourced from ClinicalTrials.gov (NCT03590457). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.